98%
921
2 minutes
20
Background: Leishmaniosis and other canine vector-borne diseases (CVBDs) pose a major risk for veterinary and public health globally, especially where humans and dogs live in close proximity. Although mosquito and tick vectors are abundant in Hong Kong, surveillance for CVBDs has been limited.
Methods: A serological and molecular survey of 158 healthy owned (n = 64) and free-roaming unowned (n = 94) dogs with outdoor access in Hong Kong was performed to determine CVBD prevalence. Point-of-care (POC) immunoassays were used to detect (i) antibodies to Leishmania spp., Ehrlichia spp., and Anaplasma spp., and (ii) Dirofilaria immitis and Angiostrongylus vasorum antigens, in canine sera. Conventional polymerase chain reaction (PCR) was also carried out to detect the molecular prevalence of all five pathogens as well as Hepatazoon canis, Babesia gibsoni, and Trypanosoma evansi. In addition, for Leishmania spp. detection, an immunofluorescence antibody test (IFAT) was performed on all serum samples, followed by real-time PCR of seropositive samples to detect Leishmania spp. DNA. The agreement between tests was assessed by Cohen's kappa statistic, and logistic regression analysis was applied to identify potential risk factors.
Results: Overall, 45.6% of dogs tested positive on molecular and/or serological tests for at least one pathogen, with the highest prevalence recorded for Dirofilaria spp. (20.9%), followed by B. gibsoni (15.2%), Leishmania spp. (11.4%), Anaplasma spp. (7.6%), H. canis (4.4%), Ehrlichia spp. (3.8%), and A. vasorum (0.6%). No T. evansi DNA was detected. Co-infections or co-pathogen exposure occurred in 16.5% of samples. Of the 33 Dirofilaria spp.-positive dogs, two were identified by sequencing as Dirofilaria asiatica, and the remaining 31 were D. immitis. No significant risk factors for infection or exposure were identified.
Conclusions: This is the first epidemiological survey of Leishmania spp. infection in dogs from Hong Kong, highlighting the need for surveillance of competent vectors and further investigation of disease status in dog populations to confirm whether this pathogen is endemic. Given the high prevalence of CVBD, especially of D. immitis, preventive and control measures are advocated in order to mitigate risks to canine health and zoonotic infection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12278506 | PMC |
http://dx.doi.org/10.1186/s13071-025-06853-5 | DOI Listing |
Microb Pathog
September 2025
Department of Biotechnology, Jamia Millia Islamia (A Central University), New Delhi, 110025, India. Electronic address:
Leishmania donovani is an intracellular protozoan parasite that has successfully evolved to manipulate host macrophages. The exact mechanism by which Leishmania spp evades macrophage function is not fully understood. Recently, several studies have shown that pathogens target host-microRNA to alter cellular pathways for their persistence.
View Article and Find Full Text PDFActa Trop
September 2025
Laboratório de Parasitologia Médica e Biologia de Vetores, Faculdade de Medicina, Universidade de Brasília, DF, Brasil. Electronic address:
Phlebotomine sand flies are known vectors of Leishmania spp. to mammals, but also may transmit Sauroleishmania, and Trypanosoma spp. to reptiles and amphibians.
View Article and Find Full Text PDFMol Biochem Parasitol
September 2025
Institute of Microbiology, University of Agriculture, Faisalabad, Pakistan.
Parasitic diseases caused by Leishmania spp. create considerable health concerns in animals, resulting in a considerable financial impact. They causes a complex infection in equines, affecting weight gain, skin, liver, and spleen.
View Article and Find Full Text PDFEur J Med Chem
August 2025
Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133, Milan, Italy.
Vector-borne parasitic diseases (VBPDs) represent a major global public health concern, with human African trypanosomiasis (HAT), Chagas disease, leishmaniasis, and malaria collectively threatening millions of people, particularly in developing regions. Climate change may further influence their transmission and geographic spread, increasing the global burden. As drug resistance continues to rise, there is an urgent need for novel therapeutic agents to expand treatment options and limit disease progression.
View Article and Find Full Text PDFExp Parasitol
September 2025
Natural Products Drug Discovery Research Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK. Electronic address:
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania spp., for which there is no vaccine and an urgent need for better drugs. The zinc metalloprotease gp63 of Leishmania has been identified as an antigenic structure for vaccine design and a promising target for new antileishmanial agents.
View Article and Find Full Text PDF